Ticker
CRVOCompany Name
CERVOMED INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Depreciation, Amortization & Accretion | Earning Before Interest & Taxes (EBIT) | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) |
---|---|---|---|
6/30/2025 | $ 0 | $ -22.61M | $ -22.61M |
3/31/2025 | $ 0 | $ -18.67M | $ -18.67M |
12/31/2024 | $ 0 | $ -16.29M | $ -16.29M |
9/30/2024 | $ 0 | $ -11.95M | $ -11.95M |
6/30/2024 | $ 0 | $ -5.04M | $ -5.04M |
3/31/2024 | $ 0 | $ -4.84M | $ -4.84M |
12/31/2023 | $ 0 | $ -2.17M | $ -2.17M |
9/30/2023 | $ 0 | $ -8.13M | $ -8.13M |
6/30/2023 | $ 0 | $ -13.08M | $ -13.08M |
3/31/2023 | $ 0 | $ -15.16M | $ -15.16M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT + DepAmor
(=) EBITDA
EBITDA for CERVOMED INC is calculated as follows: EBIT [ $ -14.82M ] + DepAmor [ $ 105.31K ]
(=) EBITDA [ $ -14.71M ]
Minimum
Sep 30, 2021
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.24K |
---|---|
min | $ -493.3M |
max | $ 590.6M |
average | $ 58.9M |
median | $ 8.92M |
std | $ 167.01M |